{"id":231814,"date":"2026-01-20T12:03:39","date_gmt":"2026-01-20T12:03:39","guid":{"rendered":"https:\/\/sources-matter.com\/?p=231814"},"modified":"2026-02-10T15:53:26","modified_gmt":"2026-02-10T15:53:26","slug":"reach-priloha-xiv-echa-konzultace","status":"publish","type":"post","link":"https:\/\/sources-matter.com\/en\/reach-priloha-xiv-echa-konzultace\/sources-matter","title":{"rendered":"Na\u0159\u00edzen\u00ed REACH: \u010cty\u0159i l\u00e1tky mohou zam\u00ed\u0159it na p\u0159\u00edlohu XIV EU Na\u0159\u00edzen\u00ed REACH"},"content":{"rendered":"\n<p><a href=\"https:\/\/echa.europa.eu\/cs\/\" target=\"_blank\" rel=\"noopener\">ECHA<\/a><a>\u00a0<\/a>zah\u00e1jila konzultaci k n\u00e1vrhu doporu\u010den\u00ed na za\u0159azen\u00ed \u010dty\u0159 l\u00e1tek na p\u0159\u00edlohu XIV, l\u00e1tky podl\u00e9haj\u00edc\u00ed povolen\u00ed dle\u00a0<a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/CS\/ALL\/?uri=celex%3A32006R1907\" target=\"_blank\" rel=\"noopener\">EU Na\u0159\u00edzen\u00ed REACH<\/a> (Registration, Evaluation, Authorisation and Restriction of Chemicals). P\u0159ipom\u00ednky k n\u00e1vrhu je mo\u017en\u00e9 zas\u00edlat do 2. kv\u011btna 2026.<\/p>\n\n\n\n<p>Po p\u0159\u00edpadn\u00e9m za\u0159azen\u00ed t\u011bchto l\u00e1tek na seznam l\u00e1tek podl\u00e9haj\u00edc\u00ed povolen\u00ed spole\u010dnosti povinny po\u017e\u00e1dat o autorizaci, pokud budou cht\u00edt l\u00e1tky nad\u00e1le pou\u017e\u00edvat nebo je uv\u00e1d\u011bt na trh.<\/p>\n\n\n\n<p><strong>L\u00e1tky, kter\u00e9 ECHA doporu\u010duje za\u0159adit na Seznam l\u00e1tek podl\u00e9haj\u00edc\u00ed povolen\u00ed REACH:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bumetrizol (UV-326)<\/li>\n\n\n\n<li>2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)fenol (UV-329)<\/li>\n\n\n\n<li>trifenylfosf\u00e1t<\/li>\n\n\n\n<li>2-(dimethylamino)-2-[(4-methylfenyl)methyl]-1-[4-(morfolin-4-yl)fenyl]butan-1-on<\/li>\n<\/ul>\n\n\n\n<p>Tyto l\u00e1tky jsou pou\u017e\u00edv\u00e1ny v r\u016fzn\u00fdch pr\u016fmyslov\u00fdch aplikac\u00edch a byly identifikov\u00e1ny jako l\u00e1tky vzbuzuj\u00edc\u00ed mimo\u0159\u00e1dn\u00e9 obavy (SVHC), u nich\u017e je zva\u017eov\u00e1no dal\u0161\u00ed zp\u0159\u00edsn\u011bn\u00ed jejich pou\u017e\u00edv\u00e1n\u00ed.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Co je c\u00edlem prob\u00edhaj\u00edc\u00ed konzultace?<\/h3>\n\n\n\n<p>ECHA v r\u00e1mci konzultace shroma\u017e\u010fuje dopl\u0148uj\u00edc\u00ed informace zejm\u00e9na o:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Aktu\u00e1ln\u00edm pou\u017eit\u00ed l\u00e1tek<\/li>\n\n\n\n<li>Objemech uv\u00e1d\u011bn\u00fdch na trh<\/li>\n\n\n\n<li>Mo\u017en\u00fdch v\u00fdjimk\u00e1ch z autoriza\u010dn\u00ed povinnosti<\/li>\n\n\n\n<li>Struktu\u0159e a slo\u017eitosti dodavatelsk\u00fdch \u0159et\u011bzc\u016f<\/li>\n<\/ul>\n\n\n\n<p>Registrovan\u00e9 subjekty i n\u00e1sledn\u00ed u\u017eivatel\u00e9 jsou vyzv\u00e1ni, aby zajistili, \u017ee informace o pou\u017eit\u00ed jsou aktu\u00e1ln\u00ed v registra\u010dn\u00edch dokumentac\u00edch REACH, a z\u00e1rove\u0148 aby poskytli sv\u00e9 p\u0159ipom\u00ednky v r\u00e1mci konzultace.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Co bude n\u00e1sledovat?<\/h3>\n\n\n\n<p>Na z\u00e1klad\u011b v\u00fdsledk\u016f konzultace p\u0159iprav\u00ed MSC (V\u00fdbor \u010dlensk\u00fdch st\u00e1t\u016f) sv\u00e9 stanovisko, kter\u00e9 bude podkladem pro kone\u010dn\u00e9 doporu\u010den\u00ed ECHA Evropsk\u00e9 komisi. Evropsk\u00e1 komise n\u00e1sledn\u011b rozhodne:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kter\u00e9 l\u00e1tky budou za\u0159azeny na Seznam l\u00e1tek podl\u00e9haj\u00edc\u00ed povolen\u00ed<\/li>\n\n\n\n<li>Jak\u00e9 podm\u00ednky pro jejich pou\u017eit\u00ed budou stanoveny<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Jak autorizace ovlivn\u00ed pou\u017e\u00edv\u00e1n\u00ed l\u00e1tek?<\/h3>\n\n\n\n<p>Pokud je l\u00e1tka za\u0159azena na Seznam l\u00e1tek podl\u00e9haj\u00edc\u00ed povolen\u00ed, nesm\u00ed b\u00fdt po stanoven\u00e9m datu pou\u017e\u00edv\u00e1na ani uv\u00e1d\u011bna na trh, pokud nen\u00ed pro konkr\u00e9tn\u00ed pou\u017eit\u00ed ud\u011blena autorizace. O autorizaci mohou \u017e\u00e1dat spole\u010dnosti, kter\u00e9 l\u00e1tky:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Pou\u017e\u00edvaj\u00ed<\/li>\n\n\n\n<li>Vyr\u00e1b\u011bj\u00ed<\/li>\n\n\n\n<li>Dov\u00e1\u017eej\u00ed<\/li>\n<\/ul>\n\n\n\n<p><strong>Hlavn\u00edm c\u00edlem autoriza\u010dn\u00edho procesu je:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Postupn\u00e9 nahrazov\u00e1n\u00ed l\u00e1tek SVHC (pokud jsou k dispozici technicky a ekonomicky provediteln\u00e9 alternativy)<\/li>\n\n\n\n<li>Zaji\u0161t\u011bn\u00ed \u0159\u00e1dn\u00e9 kontroly rizik pro lidsk\u00e9 zdrav\u00ed a \u017eivotn\u00ed prost\u0159ed\u00ed do doby, ne\u017e budou tyto l\u00e1tky nahrazeny<\/li>\n<\/ul>\n\n\n\n<p>Posledn\u00ed aktualizace Kandid\u00e1tsk\u00e9ho seznamu SVHC prob\u011bhla v \u00fanoru 2026. Podle ECHA seznam nyn\u00ed obsahuje 253 polo\u017eek. P\u0159e\u010dt\u011bte se tento \u010dl\u00e1nek\u00a0<a href=\"https:\/\/sources-matter.com\/blog-aktuality-clanky\">zde.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ECHA\u00a0zah\u00e1jila konzultaci k n\u00e1vrhu doporu\u010den\u00ed na za\u0159azen\u00ed \u010dty\u0159 l\u00e1tek na p\u0159\u00edlohu XIV, l\u00e1tky podl\u00e9haj\u00edc\u00ed povolen\u00ed dle\u00a0EU Na\u0159\u00edzen\u00ed REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals). P\u0159ipom\u00ednky k n\u00e1vrhu je mo\u017en\u00e9 zas\u00edlat do 2. kv\u011btna 2026. Po p\u0159\u00edpadn\u00e9m za\u0159azen\u00ed t\u011bchto l\u00e1tek na seznam l\u00e1tek podl\u00e9haj\u00edc\u00ed povolen\u00ed spole\u010dnosti povinny po\u017e\u00e1dat o autorizaci, pokud budou cht\u00edt l\u00e1tky nad\u00e1le [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":231816,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[123],"tags":[],"class_list":["post-231814","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-narizeni-reach"],"_links":{"self":[{"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/posts\/231814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/comments?post=231814"}],"version-history":[{"count":1,"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/posts\/231814\/revisions"}],"predecessor-version":[{"id":231817,"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/posts\/231814\/revisions\/231817"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/media\/231816"}],"wp:attachment":[{"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/media?parent=231814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/categories?post=231814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sources-matter.com\/en\/wp-json\/wp\/v2\/tags?post=231814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}